(Q33494306)
Statements
A phase I study of 1,2-diamminomethyl-cyclobutane-platinum (II)-lactate (D-19466; lobaplatin) administered daily for 5 days (English)
D T Sleijfer
P H Willemse
H J Guchelaar
D R Uges
P Aulenbacher
R Voegeli
1 February 1993